Amiodarone Infusion Protocol for Life-Threatening Ventricular Arrhythmias

Initial Loading and Maintenance Protocol

• The American Heart Association recommends administering an initial loading dose of 150 mg IV over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for the remaining 18 hours, with a maximum total dose of 2.2 g over 24 hours, for patients with life-threatening ventricular arrhythmias 1
• For cardiac arrest with VF/pulseless VT unresponsive to defibrillation and epinephrine, the American College of Cardiology suggests using 300 mg IV/IO bolus over 10 minutes, with a second 150 mg bolus if the rhythm persists 2

Administration and Monitoring

• The American Heart Association advises that for concentrations >2 mg/mL, a central line is mandatory, and for infusions >1 hour, do not exceed 2 mg/mL concentration unless using a central line, to prevent severe peripheral vein phlebitis 1
• Close monitoring is required for dose-related adverse effects, including hypotension (occurs in 16% of IV patients), bradycardia (occurs in 4.9% of IV patients), AV block and heart block, QT prolongation, and phlebitis at infusion site 1, 3

Amiodarone Administration Guidelines

Pediatric Considerations

• In pediatric patients, a 5 mg/kg rapid bolus (maximum 300 mg) IV/IO may be administered, with a possible repeat up to a total daily dose of 15 mg/kg, according to the Pediatrics guideline society 4
• A defibrillator must be immediately available during amiodarone administration in pediatric patients, as recommended by the Pediatrics guideline society 4

Contraindications and Precautions

• The American Academy of Pediatrics recommends that amiodarone should not be administered without a pacemaker in patients with second- or third-degree AV block, sick sinus syndrome, or severe sinus node dysfunction, and is also contraindicated in patients who have had a heart transplant 4

Amiodarone Infusion Protocol for Life-Threatening Ventricular Arrhythmias

Contraindications and Efficacy

• The American College of Cardiology recommends that amiodarone should not be administered without a pacemaker in patients with second- or third-degree AV block, as stated in the Journal of the American College of Cardiology in 1996 5
• Amiodarone demonstrates dose-response efficacy in refractory ventricular arrhythmias, with higher doses (500-1000 mg/24h) showing significantly longer time to first arrhythmic event compared to lower doses (125 mg/24h), and is equally effective as bretylium but better tolerated with less hypotension, according to the Journal of the American College of Cardiology in 1996 5, 6

Amiodarone Infusion Protocol for Life-Threatening Arrhythmias

Standard Infusion Protocol

• The American Heart Association recommends administering amiodarone as a 150 mg IV bolus over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for the remaining 18 hours (total 1,050 mg over 24 hours) for adult patients with life-threatening ventricular arrhythmias 7
• The American College of Cardiology suggests a rapid bolus of 150 mg IV diluted in 100 mL D5W over 10 minutes for initial loading 7
• The European Society of Cardiology recommends a first maintenance infusion of 1 mg/min for 6 hours (360 mg total) 7
• The American Heart Association recommends a second maintenance infusion of 0.5 mg/min for remaining 18 hours (540 mg total) 7

Cardiac Arrest Protocol

• The European Resuscitation Council suggests a 300 mg IV/IO bolus over 10 minutes for VF/pulseless VT unresponsive to defibrillation 8
• The European Resuscitation Council recommends a second dose of 150 mg IV/IO if rhythm persists 8

Pre-Existing Conditions: Critical Modifications

• The American College of Cardiology states that second- or third-degree AV block without functioning pacemaker is an absolute contraindication for amiodarone administration 9
• The American Heart Association recommends using amiodarone with extreme caution in hepatic dysfunction 7, 9
• The American College of Cardiology suggests that amiodarone is contraindicated in acute inflammatory lung disease 7, 9

Critical Drug Interactions During IV Infusion

• The American Heart Association recommends reducing digoxin dose by 50% when starting amiodarone (levels will double) 9
• The American College of Cardiology suggests reducing warfarin dose by 33-50% and monitoring INR at least weekly (interaction peaks at 7 weeks) 9
• The American Heart Association recommends avoiding concomitant QT-prolonging drugs without expert consultation 9

IV Amiodarone Dosing, Supplemental Bolus Limits, and Contraindications

Loading and Maintenance Infusion Protocol

• Loading dose: Administer 150 mg of amiodarone diluted in 100 mL of D5W over 10 minutes, followed by a continuous infusion of 1 mg/min for the first 6 hours (≈360 mg total). (American College of Cardiology) 10
• Maintenance infusion (first 6 h): Continue at 1 mg/min, delivering a total of about 360 mg during this period. (American College of Cardiology; European Society of Cardiology) 11
• Maintenance infusion (next 18 h): Reduce the rate to 0.5 mg/min, providing an additional ≈540 mg over the remaining 18 hours. (American College of Cardiology; European Society of Cardiology) 12
• Maximum daily exposure: Do not exceed a total amiodarone dose of 2.2 g within any 24‑hour interval. (American College of Cardiology) 10

Supplemental Bolus Limits for Breakthrough Arrhythmias

• Maximum supplemental boluses: In patients with refractory ventricular fibrillation or hemodynamically unstable ventricular tachycardia, up to 6–8 additional 150 mg boluses (each diluted in 100 mL D5W and infused over 10 minutes) may be given within a 24‑hour period. (European Society of Cardiology) 12

Absolute Contraindications

• Requirement for a functioning pacemaker: Amiodarone must not be administered to patients who have second‑ or third‑degree atrioventricular block or sick‑sinus syndrome unless a reliable pacemaker is in place. (American College of Cardiology) 11

IV Amiodarone Infusion Dosing and Safety Guidelines

Dosing Regimen

• Initial bolus and 24‑hour infusion schedule: Give a 150 mg IV bolus over 10 minutes, then infuse at 1 mg/min for the next 6 hours (≈360 mg), followed by 0.5 mg/min for the remaining 18 hours (≈540 mg), resulting in a total dose of about 1,050 mg in the first 24 hours. 13

Maximum Cumulative Dose

• 24‑hour dose ceiling: Do not exceed a cumulative dose of 2.2 g of IV amiodarone within any 24‑hour period. 13

Management of Infusion‑Related Hypotension

• Response to hypotension during bolus: If hypotension develops while administering the initial bolus, slow or temporarily pause the infusion; the majority of hypotensive episodes are linked to the rapid bolus rather than the subsequent maintenance infusion. 13

Management of Hemodynamic Instability

• Escalation to electrical therapy: In patients who become hemodynamically unstable at any point during IV amiodarone therapy, immediate synchronized cardioversion should be performed instead of continuing pharmacologic treatment. 13

IV Amiodarone Dosing and Monitoring for Life‑Threatening Ventricular Arrhythmias

Dosing Protocol

• Loading dose: Give an IV bolus of 150 mg (≈2 mg/kg for a 70‑kg adult) diluted in 100 mL of 5 % dextrose in water, infused over 10 minutes for hemodynamically unstable ventricular tachycardia or ventricular fibrillation. 14
• Early maintenance infusion (first 6 hours): Continue at a rate of 1 mg/min, delivering approximately 360 mg over the 6‑hour period. 14
• Late maintenance infusion (hours 7‑24): Reduce the rate to 0.5 mg/min for the remaining 18 hours, adding roughly 540 mg to the total exposure. 14
• Maximum 24‑hour exposure: Do not exceed a cumulative dose of 2.2 g within any 24‑hour window. 14

Administration Considerations

• Concentration limits: When using peripheral IV access, keep the amiodarone concentration ≤2 mg/mL; higher concentrations require central venous access to avoid severe phlebitis. 14
• IV access selection: Peripheral lines are acceptable if the ≤2 mg/mL limit is respected; otherwise a central line is mandated. 14

Monitoring and Safety

• Electrocardiographic monitoring: Continuous ECG is required; bradycardia occurs in about 4.9 % of patients, with risk of AV block, QT prolongation, and QRS changes. 14
• Hemodynamic monitoring: Hypotension develops in 16‑26 % of patients and is directly related to infusion rate; adjust rate if hypotension occurs. 14

Contraindications

• Absolute contraindication: Presence of second‑ or third‑degree AV block without a functioning pacemaker precludes amiodarone use. 14

Drug Interactions

• Digoxin: Reduce the digoxin dose by 50 % when initiating amiodarone; serum digoxin concentrations are expected to double. 14
• Warfarin: Decrease warfarin dose by 30‑50 % and monitor INR weekly for six weeks; the interaction peaks around week 7. 14

Amiodarone Dosing and Management for Acute Ventricular Tachycardia

Recommended Intravenous Regimen for Hemodynamically Stable Monomorphic VT

• Initial loading dose: 150 mg amiodarone diluted in 100 mL 5 % dextrose, infused over 10 minutes.
• Early maintenance infusion: 1 mg/min for the next 6 hours (≈360 mg total).
• Late maintenance infusion: 0.5 mg/min for the subsequent 18 hours (≈540 mg total).
• Maximum daily exposure: Do not exceed a total of 2.2 g within 24 hours.

High‑Dose 300 mg Bolus Reserved for Cardiac Arrest

• A single 300 mg IV bolus administered over 1 hour (or 10 minutes) is indicated only for cardiac arrest presenting with ventricular fibrillation or pulseless VT that is refractory to defibrillation and epinephrine. This dose is not recommended for stable VT. 15

Contraindications and Safety Alerts

• Amiodarone is absolutely contraindicated in patients with second‑ or third‑degree atrioventricular block unless a functional pacemaker is in place. 15

When to Abandon Pharmacologic Therapy and Use Synchronized Cardioversion

• Immediate synchronized cardioversion should be performed if any of the following develop during amiodarone therapy:
• In hemodynamically unstable patients, electrical therapy supersedes continued drug infusion. 15

Rationale for the 150 mg Bolus + Infusion Strategy in Stable VT

• The 150 mg bolus followed by continuous infusion provides sufficient drug loading while minimizing the risk of hypotension and ensures sustained plasma concentrations as the anti‑arrhythmic effect of amiodarone typically manifests 20–30 minutes after administration and often requires a cumulative dose of ≥1 g. 15

Alternative Anti‑arrhythmic Agents When Amiodarone Is Unsuitable